GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
91 hedge funds and large institutions have $559M invested in GenMark Diagnostics, Inc in 2016 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
+14
Holders Change %
+18.18%
% of All Funds
2.43%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
21
Increased
33
Reduced
24
Closed
7
Calls
$248K
Puts
–
Net Calls
+$248K
Net Calls Change
+$252K
Top Buyers
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$23.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13M |
| 3 |
Morgan Stanley
New York
|
+$10.4M |
| 4 |
Millennium Management
New York
|
+$6.57M |
| 5 |
JPMorgan Chase & Co
New York
|
+$4.41M |
Top Sellers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$11.4M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$5.89M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$5.65M |
| 4 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$4.23M |
| 5 |
Jennison Associates
New York
|
-$2.04M |
